Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference55 articles.
1. HIV: biology to treatment;Verma,2020
2. UNAIDS 2019. https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf.
3. Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance;Xavier Ruiz;Curr Opin Struct Biol,2020
4. Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years;Zhuang;Acta Pharm Sin B,2020
5. Fifty years in search of selective antiviral drugs;De Clercq;J Med Chem,2019
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of 2,4,6-trisubstituted pyrimidine derivatives as novel potent HIV-1 NNRTIs by exploiting the tolerant region II of the NNIBP;European Journal of Medicinal Chemistry;2024-11
2. Discovery of Novel Amino Acids (Analogues)-Substituted Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Design, Synthesis, and Biological Evaluation;International Journal of Molecular Sciences;2024-08-20
3. Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV-1 NNRTIs;Journal of Medicinal Chemistry;2024-04-13
4. A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication;International Journal of Molecular Sciences;2024-03-25
5. Efavirenz cocrystals with Ascorbic acid: A Strategy for Polymorphic Modification and improvement of Dissolution properties;Research Journal of Pharmacy and Technology;2024-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3